|Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in …|
M Nauck, A Frid, K Hermansen, NS Shah, T Tankova, IH Mitha, ...
Diabetes care 32 (1), 84-90, 2009
|Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain|
MG Kaplitt, P Leone, RJ Samulski, X Xiao, DW Pfaff, KL O'Malley, ...
Nature genetics 8 (2), 148-154, 1994
|Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial|
MG Kaplitt, A Feigin, C Tang, HL Fitzsimons, P Mattis, PA Lawlor, ...
The Lancet 369 (9579), 2097-2105, 2007
|Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain|
MJ During, DD Spencer
The lancet 341 (8861), 1607-1610, 1993
|VEGF links hippocampal activity with neurogenesis, learning and memory|
L Cao, X Jiao, DS Zuzga, Y Liu, DM Fong, D Young, MJ During
Nature genetics 36 (8), 827-835, 2004
|Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective|
D Young, PA Lawlor, P Leone, M Dragunow, MJ During
Nature medicine 5 (4), 448-453, 1999
|Glucagon-like peptide-1 receptor is involved in learning and neuroprotection|
MJ During, L Cao, DS Zuzga, JS Francis, HL Fitzsimons, X Jiao, RJ Bland, ...
Nature medicine 9 (9), 1173-1179, 2003
|Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial|
RE MacLaren, M Groppe, AR Barnard, CL Cottriall, T Tolmachova, ...
The Lancet 383 (9923), 1129-1137, 2014
|The endocannabinoid system controls key epileptogenic circuits in the hippocampus|
K Monory, F Massa, M Egertová, M Eder, H Blaudzun, R Westenbroek, ...
Neuron 51 (4), 455-466, 2006
|AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial|
PA LeWitt, AR Rezai, MA Leehey, SG Ojemann, AW Flaherty, ...
The Lancet Neurology 10 (4), 309-319, 2011
|Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach|
W Lu, Y Shi, AC Jackson, K Bjorgan, MJ During, R Sprengel, PH Seeburg, ...
Neuron 62 (2), 254-268, 2009
|Adenosine: a potential mediator of seizure arrest and postictal refractoriness|
MJ During, DD Spencer
Annals of neurology 32 (5), 618-624, 1992
|Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase|
MJ During, JR Naegele, KL O'Malley, AI Geller
Science 266 (5189), 1399-1403, 1994
|Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release|
WP Borg, RS Sherwin, MJ During, MA Borg, GI Shulman
Diabetes 44 (2), 180-184, 1995
|Hippocampal GABA transporter function in temporal-lobe epilepsy|
MJ During, KM Ryder, DD Spencer
Nature 376 (6536), 174-177, 1995
|Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1|
H Johnen, S Lin, T Kuffner, DA Brown, VWW Tsai, AR Bauskin, L Wu, ...
Nature medicine 13 (11), 1333-1340, 2007
|Subthalamic GAD gene therapy in a Parkinson's disease rat model|
J Luo, MG Kaplitt, HL Fitzsimons, DS Zuzga, Y Liu, ML Oshinsky, ...
Science 298 (5592), 425-429, 2002
|White to brown fat phenotypic switch induced by genetic and environmental activation of a hypothalamic-adipocyte axis|
L Cao, EY Choi, X Liu, A Martin, C Wang, X Xu, MJ During
Cell metabolism 14 (3), 324-338, 2011
|An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy|
MJ During, CW Symes, PA Lawlor, J Lin, J Dunning, HL Fitzsimons, ...
Science 287 (5457), 1453-1460, 2000
|Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia.|
WP Borg, MJ During, RS Sherwin, MA Borg, ML Brines, GI Shulman
The Journal of clinical investigation 93 (4), 1677-1682, 1994